Cargando…
Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells
Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands has made significant progress in recent years, both in regards to the structural design of the conjugates and their biological effectiveness. The goal of targeting specific cell surface receptors through struc...
Autores principales: | Gilad, Yosi, Firer, Michael, Gellerman, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344250/ https://www.ncbi.nlm.nih.gov/pubmed/28536378 http://dx.doi.org/10.3390/biomedicines4020011 |
Ejemplares similares
-
Targeted drug delivery for cancer therapy: the other side of antibodies
por: Firer, Michael A, et al.
Publicado: (2012) -
Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
por: Kalimuthu, Kalishwaralal, et al.
Publicado: (2018) -
Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
por: Furman, Olga, et al.
Publicado: (2022) -
Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
por: Gilad, Yosi, et al.
Publicado: (2021) -
Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery
por: Rozovsky, Alex, et al.
Publicado: (2019)